Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19

Abstract excerpt

Thromboembolic events are frequently reported in patients infected with the SARS-CoV-2 virus. The exact mechanisms of COVID-19-associated hypercoagulopathy, however, remain elusive. Recently, we observed that platelets (PLTs) from patients with severe COVID-19 infection express high levels of procoagulant markers, which were found to be associated with increased risk for thrombosis. In the current study, we...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to COVID-19 Clinical Research Studies
• Share to Heparin-Induced Thrombocytopenia and Thrombosis
• Share to Venous Thromboembolism Diagnosis and Management